Fox Chase Cancer Center
251
33
52
130
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
21.1%
53 terminated/withdrawn out of 251 trials
71.0%
-15.5% vs industry average
4%
11 trials in Phase 3/4
44%
57 of 130 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (251)
Communication About Sexual Health in Gynecologic Cancer
Role: lead
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
Role: lead
Genetic Information for Families After Tumor Testing Study
Role: collaborator
Penn Medicine Biobank Return of Results Program
Role: collaborator
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Role: lead
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Role: lead
Recovery Support for Bladder Cancer Patients and Caregivers
Role: collaborator
Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)
Role: collaborator
A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery
Role: collaborator
Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
Role: collaborator
Utility of CAML as Diagnostic for Early Stage Lung Cancer
Role: lead
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
Role: lead
Engaging and Activating Cancer Survivors in Genetic Services Study
Role: collaborator
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Role: collaborator
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
Role: collaborator
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
Role: lead
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
Role: lead
Adaptive Radiation Boost for Rectal Cancer
Role: lead
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Role: lead
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
Role: lead